Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure])
Author(s) -
Emma J. Birks,
Stavros G. Drakos,
Snehal R. Patel,
Brian D. Lowes,
Craig H. Selzman,
Randall C. Starling,
Jaimin R. Trivedi,
Mark S. Slaughter,
P. Alturi,
Daniel J. Goldstein,
Simon Maybaum,
John Um,
Kenneth B. Margulies,
Josef Stehlik,
Chris Cunningham,
David J. Farrar,
J. Eduardo Rame
Publication year - 2020
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.120.046415
Subject(s) - medicine , heart failure , cardiology , ejection fraction , ventricular assist device , pulmonary wedge pressure , inotrope , cardiomyopathy , clinical endpoint , ischemic cardiomyopathy , heart transplantation , prospective cohort study , randomized controlled trial
Left ventricular assist device (LVAD) unloading and hemodynamic support in patients with advanced chronic heart failure can result in significant improvement in cardiac function allowing LVAD removal; however, the rate of this is generally considered to be low. This prospective multicenter nonrandomized study (RESTAGE-HF [Remission from Stage D Heart Failure]) investigated whether a protocol of optimized LVAD mechanical unloading, combined with standardized specific pharmacological therapy to induce reverse remodeling and regular testing of underlying myocardial function, could produce a higher incidence of LVAD explantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom